| Date Filed | Type | Description |
| 10/03/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 389 shares
@ $57.77, valued at
$22.5k
|
|
| 07/05/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 390 shares
@ $62.25, valued at
$24.3k
|
|
| 06/16/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 2,505 shares
@ $0
Granted 11,294 options to buy
@ $61.44, valued at
$693.9k
|
|
| 05/19/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 3,750 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 326 shares
@ $72.27, valued at
$23.6k
|
|
| 01/04/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 302 shares
@ $80.32, valued at
$24.3k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 250 shares
@ $66.64, valued at
$16.7k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 240 shares
@ $79.42, valued at
$19.1k
|
|
| 01/04/2022 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 253 shares
@ $73.4, valued at
$18.6k
|
|
| 10/04/2021 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 237 shares
@ $68.78, valued at
$16.3k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 6,000 shares
@ $4.12, valued at
$24.7k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $83.32, valued at
$833.2k
|
|
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 30,000 shares
@ $91.79, valued at
$2.8M
|
|
| 06/08/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $97.59, valued at
$1.2M
|
|
| 06/05/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 16,000 options to buy
@ $4.86, valued at
$77.8k
|
|
| 05/28/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,282 shares
@ $0
Granted 10,514 options to buy
@ $98.68, valued at
$1M
|
|
| 04/02/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 202 shares
@ $73.23, valued at
$14.8k
|
|
| 03/11/2020 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 105,163 shares
@ $0 |
|
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|